Clinical Trial

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Name: Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies — clinical trial record (NCT07004244)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study is to evaluate the safety and efficacy of mRNA vaccine for the KRAS mutation malignant tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-26.

Status change: Not Yet Recruiting → Recruiting 2025-06-17

Trial Details

NCT Number	NCT07004244
Lead Sponsor	Sichuan University Collaborators: West China Hospital
Conditions	Malignant Tumors
Enrollment	20 participants
Start Date	2025-06-05
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-24